Results 71 to 80 of about 2,581 (157)

Drug-induced dyspnea versus cystic fibrosis exacerbation: a diagnostic dilemma

International Medical Case Reports Journal, 2017
Saqib Walayat,1 Nooreen Hussain,1 Jaymon Patel,1 Faiz Hussain,2 Preeti Patel,1 Sonu Dhillon,1 Bhagat Aulakh,3,4 Subramanyam Chittivelu3 1Department of Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, 2Department of ...
Walayat S, Hussain N, Patel J, Hussain F, Patel P, Dhillon S, Aulakh B, Chittivelu S   +7 more
doaj  

In Silico Evaluation of Lumacaftor for Cystic Fibrosis

PARIPEX INDIAN JOURNAL OF RESEARCH
Abstract Cystic fibrosis is a common life-limiting autosomal recessive genetic disorder that causes severe damage to lungs, digestive system and other organs in the body. This disease is a result of mutation in a gene that encodes for chloride-conducting transmembrane channel called CFTR, which in turn regulates mucociliary clearance and anion ...
openaire   +1 more source

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL^pro: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis. [PDF]

ACS Pharmacol Transl Sci
Lueangaramkul V, Mana N, Thangthamniyom N, Semkum P, Lekcharoensuk P, Limprasutr V, Theerawatanasirikul S.   +6 more
europepmc   +1 more source

In Vitro Restoration of Colistin Susceptibility by Ivacaftor Synergy with Limited Reproducibility in a Murine Pneumonia Model. [PDF]

Antibiotics (Basel)
Halperin AV, Schwartz F, Christophersen L, Pérez-Del Palacio J, Ponce-Alonso M, Avendaño-Ortiz J, Caballero JD, Cantón R, Moser C, Del Campo R.   +9 more
europepmc   +1 more source

Post-marketing safety profile of lumacaftor/ivacaftor in cystic fibrosis treatment: a pharmacovigilance analysis based on FAERS. [PDF]

Front Med (Lausanne)
Wang T, Yang W, Luo Y, Zhan Y, Zou F, Cui Z, Lan Y.   +6 more
europepmc   +1 more source

PopMAG: a Nextflow pipeline for population genetics analysis based on metagenome-assembled genomes. [PDF]

Bioinform Adv
Sabogal-Rodriguez D, Caro-Quintero A.
europepmc   +1 more source

Predictive capacity of paediatric nasal epithelial cells in sequential CFTR modulator therapy. [PDF]

Thorax
Fawcett LK, Chew ZA, Schneider-Futschik EK, Allan KM, Patel HR, Jaffe A, Waters S.   +6 more
europepmc   +1 more source

Discovery of novel repurposed anthelminthics against <i>Trichinella spiralis</i> and albendazole-resistant nematodes through metabolomics-guided virtual screening. [PDF]

Curr Res Parasitol Vector Borne Dis
Chienwichai P, Tipthara P, Tarning J, Thiangtrongjit T, Supasawat P, Adisakwattana P, Reamtong O.   +6 more
europepmc   +1 more source

NAALADL1 modulates cellular resistance to Tumor Treating Fields in colorectal cancer. [PDF]

NPJ Precis Oncol
Su Z, Liu M, Krohn M, Ostermann J, Schwarz S, Hahn O, Frank M, Gemoll T, Schafmayer C, Linnebacher M.   +9 more
europepmc   +1 more source

Greenness, Whiteness, and Blueness Assessment With a Novel and Fully Validated HPLC Method for Simultaneous Analysis of Lumacaftor and Ivacaftor in Sweat. [PDF]

Int J Anal Chem
Levent S, Elriş A, Özcan S, Can NÖ.
europepmc   +1 more source